Sat10252014

Last update 09:49:55 AM EST

NASP Announces 2015 Annual Meeting & Expo in Washington, DC

NASP Announces 2015 Annual Meeting & Expo in Washington, DC

Education Tracks in general specialty pharmacy, sp...

FDA Panel Recommends Expanding Approval of Vertex's Cystic Fibrosis Drug

FDA Panel Recommends Expanding Approval of Vertex's Cystic Fibrosis Drug

A Food and Drug Administration (FDA) advisory co...

AbbVie and Shire Terminate Merger Agreement

AbbVie and Shire Terminate Merger Agreement

US-based AbbVie and Ireland-based Shire announ...

Omeros Halts Mid-Stage Huntington's Disease Study

Omeros Halts Mid-Stage Huntington's Disease Study

Omeros Corporation has followed the US Food an...

FDA Approves Baxter's Obizur for Treatment of Acquired Hemophilia A

FDA Approves Baxter's Obizur for Treatment of Acquired Hemophilia A

Today, Baxter International Inc. announced that its hemophilia A drug has been...

AstraZeneca's Ovarian Cancer Drug Gets Backing from EU Agency

AstraZeneca's Ovarian Cancer Drug Gets Backing from EU Agency

Today, AstraZeneca announced that the European Medicines Agency’s (EMA) Comm...

Study Finds Early Palliative Care Can Reduce Hospital Readmission Rates for Cancer Patients

Study Finds Early Palliative Care Can Reduce Hospital Readmission Rates for Cancer Patients

Physicians at Duke University Hospital have developed a new collaborative mo...

Imbruvica sNDA Submitted to the FDA for Treatment of Rare Blood Cancer

Imbruvica sNDA Submitted to the FDA for Treatment of Rare Blood Cancer

Today, Janssen Research & Development, LLC announced that its strategic pa...

Celgene Expands its Deal with Sutro Biopharma to Include Immuno-Oncology and a Buyout Option

Celgene Expands its Deal with Sutro Biopharma to Include Immuno-Oncology and a Buyout Option

Celgene is expanding its nearly two-year-old cancer collaboration with Sutro B...

NASP Announces 2015 Annual Meeting & Expo in Washington, DC

NASP Announces 2015 Annual Meeting & Expo in Washington, DC

Education Tracks in general specialty pharmacy, specialty pharmacy and payers, a...

AbbVie and Shire Terminate Merger Agreement

AbbVie and Shire Terminate Merger Agreement

US-based AbbVie and Ireland-based Shire announced that they have officially ...

Genentech Launches $1.15 Billion Cancer Collaboration with NewLink Genetics

Genentech Launches $1.15 Billion Cancer Collaboration with NewLink Genetics

NewLink Genetics has agreed to license its early-stage cancer program to Gen...

Regulus' Lead microRNA Therapy Demonstrates Positive Results in Treating Hepatitis C

Regulus' Lead microRNA Therapy Demonstrates Positive Results in Treating Hepatitis C

Today, Regulus Therapeutics Inc. announced that it has demonstrated human pr...

FDA Committee Unanimously Recommends Approval of Novartis' Psoriasis Candidate

FDA Committee Unanimously Recommends Approval of Novartis' Psoriasis Candidate

An advisory panel to the US Food and Drug Administration (FDA) voted unanimo...

Regeneron's Eylea Beats Avastin and Lucentis in Comparative Study

Regeneron's Eylea Beats Avastin and Lucentis in Comparative Study

Regeneron Pharmaceuticals, Inc. recently announced that its Eylea (afliberce...

FDA Extends Review Date for NPS Pharma's Natpara

FDA Extends Review Date for NPS Pharma's Natpara

The US Food and Drug Administration (FDA) has postponed its final decision on ...

Novartis' Secukinumab Demonstrates Positive Results in Spinal Inflammation Trial

Novartis' Secukinumab Demonstrates Positive Results in Spinal Inflammation Trial

Following the US Food and Drug Administration (FDA) advisory group’s unanimous...

GW's Epidiolex Granted Orphan Drug Designation by EMA

GW's Epidiolex Granted Orphan Drug Designation by EMA

The European Medicines Agency (EMA) has granted GW Pharmaceuticals' investigat...

FDA Panel Recommends Expanding Approval of Vertex's Cystic Fibrosis Drug

FDA Panel Recommends Expanding Approval of Vertex's Cystic Fibrosis Drug

A Food and Drug Administration (FDA) advisory committee has recommended approv...

Omeros Halts Mid-Stage Huntington's Disease Study

Omeros Halts Mid-Stage Huntington's Disease Study

Omeros Corporation has followed the US Food and Drug Administration’s (FDA) ...

Celgene's Experimental Crohn's Disease Drug Demonstrates Positive Mid-Stage Results

Celgene's Experimental Crohn's Disease Drug Demonstrates Positive Mid-Stage Results

Today, Celgene presented a first detailed look at its recently acquired, exper...